Metraipolis › archive › dc_8df38cb70de3
Melflufen in Multiple Myeloma: Clinical Limitations, Biological Rationale, and Future Perspectives — Europe PMC PMID:42192911
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42192911
- DOI
- 10.3390/cancers18101551
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T12:11:54.254Z
- SHA-256 of the archived text
2b14e05f92a02ea855442631f49eac57a1f73a65d0882b0f3ea48052e196a516- Stable URL of this page
https://metraipolis.com/documento/dc_8df38cb70de3
How to cite
Melflufen in Multiple Myeloma: Clinical Limitations, Biological Rationale, and Future Perspectives — Europe PMC PMID:42192911 — Europe PMC (en), https://europepmc.org/article/MED/42192911 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8df38cb70de3 (Metraipolis archive dc_8df38cb70de3, sha256 2b14e05f92a02ea855442631f49eac57a1f73a65d0882b0f3ea48052e196a516)
BibTeX
@misc{dc8df38cb70de3,
title = {Melflufen in Multiple Myeloma: Clinical Limitations, Biological Rationale, and Future Perspectives — Europe PMC PMID:42192911},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42192911},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8df38cb70de3; sha256 2b14e05f92a02ea855442631f49eac57a1f73a65d0882b0f3ea48052e196a516},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42192911. Agents can read the archived copy with the MCP tool read_document.